| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.57B | 48.93B | 46.16B | 43.97B | 41.46B | 36.60B |
| Gross Profit | 27.88B | 29.65B | 27.88B | 26.80B | 25.60B | 22.61B |
| EBITDA | 8.20B | 8.52B | 8.44B | 8.77B | 9.55B | 7.09B |
| Net Income | 4.16B | 5.41B | 4.38B | 4.24B | 3.77B | 4.52B |
Balance Sheet | ||||||
| Total Assets | 44.48B | 48.76B | 45.49B | 46.30B | 46.29B | 44.11B |
| Cash, Cash Equivalents and Short-Term Investments | 14.27B | 14.38B | 16.72B | 18.99B | 19.85B | 17.26B |
| Total Debt | 5.93B | 5.45B | 6.38B | 9.33B | 12.03B | 10.71B |
| Total Liabilities | 15.55B | 15.38B | 15.85B | 19.11B | 21.51B | 21.48B |
| Stockholders Equity | 28.63B | 33.14B | 29.28B | 26.71B | 24.28B | 22.19B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.70B | 5.86B | 6.15B | 6.88B | 5.94B |
| Operating Cash Flow | 0.00 | 6.55B | 6.33B | 6.54B | 7.18B | 6.23B |
| Investing Cash Flow | 0.00 | -5.71B | -4.41B | -3.63B | -2.88B | -1.53B |
| Financing Cash Flow | 0.00 | -2.58B | -4.44B | -4.10B | -1.77B | -5.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥64.20B | 14.86 | 13.96% | 2.16% | 13.15% | 2.96% | |
77 Outperform | ¥68.08B | 14.80 | 31.71% | 1.68% | 17.64% | 47.00% | |
70 Outperform | ¥22.02B | 7.22 | ― | 4.58% | 6.58% | 35.23% | |
69 Neutral | ¥47.76B | 9.57 | ― | 2.81% | 5.99% | 23.34% | |
66 Neutral | ¥42.27B | 18.56 | ― | 1.50% | 10.69% | 6.99% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥6.16B | 20.75 | ― | ― | 18.87% | ― |